fluorodeoxyglucose f18 has been researched along with Paraproteinemias in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Férnandez-Férnandez, J; Ramos-Font, C; Rashki, M; Rivas-Navas, D; Rudolphi-Solero, T | 1 |
| Alig, S; Alizadeh, AA; de Jong, D; Dührsen, U; Dürig, J; Hanoun, C; Hüttmann, A; Johansson, P; Klapper, W; Rekowski, J; Richter, J; Ylstra, B | 1 |
| Chen, S; Cheng, T; Cheung, SK; Chim, CS; Ho, CL; Leung, YL; Liang, R; Wong, KN | 1 |
| Choi, YY; Kim, JY; Yang, SO | 1 |
| Peller, PJ | 1 |
| Hotchi, J; Ise, T; Iwase, T; Kusunose, K; Nishio, S; Sata, M; Soeki, T; Takagawa, Y; Tobiume, T; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
| Bove, P; Colella, G; Pagliarulo, V; Tozzi, U | 1 |
| D'Agnolo, A; Durie, BG; Waxman, AD; Williams, CM | 1 |
| Adam, Z; Bolcák, K; Hájek, R; Krejcí, M; Mareschova, Y; Neubauer, J; Pour, L; Prásek, J; Stanícek, J; Vorlícek, J | 1 |
| Adam, Z; Bolcak, K; Buchler, T; Hajek, R; Krejci, M; Neubauer, J; Pour, L; Prasek, J; Stanicek, J; Vorlicek, J | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Paraproteinemias
| Article | Year |
|---|---|
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Multiple myeloma.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
8 other study(ies) available for fluorodeoxyglucose f18 and Paraproteinemias
| Article | Year |
|---|---|
[
Topics: Fluorodeoxyglucose F18; Humans; Necrobiotic Xanthogranuloma; Paraproteinemias; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphoma, Large B-Cell, Diffuse; Paraproteinemias; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies | 2023 |
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lipid Metabolism; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Paraproteinemias; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Serial imaging changes during treatment of immunoglobulin G4-related disease with multiple pseudotumors.
Topics: Aged, 80 and over; Antibodies, Anti-Idiotypic; Arteries; Cardiomegaly; Coronary Aneurysm; Eyelid Diseases; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Paraproteinemias; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Warthin tumor: a potential source of diagnostic error.
Topics: Adenolymphoma; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maxillary Neoplasms; Neoplasms, Multiple Primary; Paraproteinemias; Parotid Diseases; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Whole-body (18)F-FDG PET identifies high-risk myeloma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
[The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction | 2006 |
Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, Emission-Computed | 2007 |